aid: immunis
name: Immunis
description: >-
  Immunis, Inc. is a private, clinical-stage biotechnology company headquartered in Irvine,
  California, developing immunomodulatory secretome biologics — the mixture of proteins and factors
  secreted by stem cells, rather than the cells themselves — as a treatment for age- and
  disease-related immune decline. Its lead candidate, IMM01-STEM, is under study in the STEM-MYO
  Phase 1/2a trial for muscle atrophy and sarcopenia, alongside a STEM-META Phase 2 program and a
  STEM-K9 veterinary program. Immunis is a therapeutics developer, not a software company: it
  publishes no developer portal, API, SDK, webhook surface, or machine-readable API contract of any
  kind. Its entire public surface is a WordPress marketing and clinical-trial-recruitment site whose
  only machine-readable endpoint is the default WordPress REST API at /wp-json/, which serves the
  CMS of that site and is not an Immunis API product.
image: https://immunisbiomedical.com/wp-content/uploads/2026/06/ImmunisLogo.png
url: https://raw.githubusercontent.com/api-evangelist/immunis/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-23'
modified: '2026-08-23'
tags:
- Company
- Biotechnology
- Life Sciences
- Therapeutics
- Clinical Trials
- Regenerative Medicine
- Healthcare
- Longevity
- Sarcopenia
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/immunis-domain-security.yml
- type: LLMsTxt
  url: llms/immunis-llms.txt
- type: Website
  url: https://immunisbiomedical.com/
- type: PressReleases
  url: https://immunisbiomedical.com/press-releases/
- type: Contact
  url: https://immunisbiomedical.com/contact/
- type: LinkedIn
  url: https://www.linkedin.com/company/immunisbiomedical/
x-enrichment:
  date: '2026-08-23'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Immunis, Inc. is a clinical-stage biotech developing secretome therapeutics; its full page
    inventory (46 pages, read from the site's own sitemap) contains no developer, API or
    documentation page, and every /openapi.json, /api-docs, /graphql, /llms.txt and /.well-known/*
    probe on immunisbiomedical.com returned the WordPress 404 page — the only machine-readable
    endpoint on the host is the site's default WordPress CMS REST API at /wp-json/.
  evidence:
  - url: https://immunisbiomedical.com/openapi.json
    status: 404
  - url: https://immunisbiomedical.com/.well-known/api-catalog
    status: 404
  - url: https://immunisbiomedical.com/llms.txt
    status: 404
  - url: https://immunisbiomedical.com/developers
    status: 404
  - url: https://immunisbiomedical.com/wp-json/
    status: 200
  checked: '2026-08-23'